Wordt geladen...
Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series
BACKGROUND: Pulmonary hypertension (PH) is a known complication of pulmonary sarcoidosis and is associated with higher morbidity and mortality. Currently, there are no approved PH-targeted therapies for sarcoidosis-associated pulmonary hypertension (SAPH). Macitentan is frequently used as treatment...
Bewaard in:
| Gepubliceerd in: | Sarcoidosis Vasc Diffuse Lung Dis |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Mattioli 1885
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7569544/ https://ncbi.nlm.nih.gov/pubmed/33093771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.36141/svdld.v37i1.9292 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|